Bluebird bio Inc
BLUE
Get informed when a big investor buys or sells
+ FollowMarket Cap$48.67M
Close$
$3.82
23.1% downside
Current Fair Value
23.1% downsideOvervalued by 23.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $48.67 Million |
|---|---|
| Enterprise Value | $128.01 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-24.84 |
| Beta | 0.37 |
| Outstanding Shares | 9,751,000 |
Return
| Return on Equity | 345.59% |
|---|---|
| Return on Assets | -67.57% |
| Return on Invested Capital | 1060.71% |
Valuation & Multiples
| P/E Ratio | -0.2 |
|---|---|
| PEG | 0.34 |
| Price to Sales | 0.5 |
| Price to Book Ratio | -0.83 |
| Enterprise Value to Revenue | 1.23 |
| Enterprise Value to EBIT | -0.63 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.23 |
| Debt to Equity | -2.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data